Literature DB >> 25216770

Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer?

Hamid Bayanati1, Rebecca E Thornhill, Carolina A Souza, Vineeta Sethi-Virmani, Ashish Gupta, Donna Maziak, Kayvan Amjadi, Carole Dennie.   

Abstract

OBJECTIVE: To assess the accuracy of CT texture and shape analysis in the differentiation of benign and malignant mediastinal nodes in lung cancer.
METHODS: Forty-three patients with biopsy-proven primary lung malignancy with pathological mediastinal nodal staging and unenhanced CT of the thorax were studied retrospectively. Grey-level co-occurrence and run-length matrix textural features, as well as morphological features, were extracted from 72 nodes. Differences between benign and malignant features were assessed using Mann-Whitney U tests. Receiver operating characteristic (ROC) curves for each were constructed and the area under the curve (AUC) calculated with histopathology diagnosis as outcome. Combinations of features were also entered as predictors in logistic regression models and optimal threshold criteria were used to estimate sensitivity and specificity.
RESULTS: Using optimum-threshold criteria, the combined textural and shape features identified malignant mediastinal nodes with 81% sensitivity and 80% specificity (AUC = 0.87, P < 0.0001). Using this combination, 84% malignant and 71% benign nodes were correctly classified.
CONCLUSIONS: Quantitative CT texture and shape analysis has the potential to accurately differentiate malignant and benign mediastinal nodes in lung cancer. KEY POINTS: • Mediastinal nodal staging is crucial in the management of lung cancer • Mediastinal nodal metastasis affects prognosis and suitability for surgical treatment • Computed tomography (CT) is limited for mediastinal nodal staging • Texture analysis measures tissue heterogeneity not perceptible to human vision • CT texture analysis may accurately differentiate malignant and benign mediastinal nodes.

Entities:  

Mesh:

Year:  2014        PMID: 25216770     DOI: 10.1007/s00330-014-3420-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

2.  Influence of MRI acquisition protocols and image intensity normalization methods on texture classification.

Authors:  G Collewet; M Strzelecki; F Mariette
Journal:  Magn Reson Imaging       Date:  2004-01       Impact factor: 2.546

3.  Optical differentiation between malignant and benign lymphadenopathy by grey scale texture analysis of endobronchial ultrasound convex probe images.

Authors:  Phan Nguyen; Farzad Bashirzadeh; Justin Hundloe; Olivier Salvado; Nicholas Dowson; Robert Ware; Ian Brent Masters; Manoj Bhatt; Aravind Ravi Kumar; David Fielding
Journal:  Chest       Date:  2011-09-01       Impact factor: 9.410

4.  Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy.

Authors:  Marco Ravanelli; Davide Farina; Mauro Morassi; Elisa Roca; Giuseppe Cavalleri; Gianfranco Tassi; Roberto Maroldi
Journal:  Eur Radiol       Date:  2013-07-09       Impact factor: 5.315

5.  Non-small cell lung cancer: histopathologic correlates for texture parameters at CT.

Authors:  Balaji Ganeshan; Vicky Goh; Henry C Mandeville; Quan Sing Ng; Peter J Hoskin; Kenneth A Miles
Journal:  Radiology       Date:  2012-11-20       Impact factor: 11.105

6.  Computer-aided diagnosis applied to US of solid breast nodules by using neural networks.

Authors:  D R Chen; R F Chang; Y L Huang
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

7.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.

Authors:  Balaji Ganeshan; Elleny Panayiotou; Kate Burnand; Sabina Dizdarevic; Ken Miles
Journal:  Eur Radiol       Date:  2011-11-17       Impact factor: 5.315

8.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.

Authors:  Francesca Ng; Balaji Ganeshan; Robert Kozarski; Kenneth A Miles; Vicky Goh
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

9.  Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.

Authors:  T C McLoud; P M Bourgouin; R W Greenberg; J P Kosiuk; P A Templeton; J A Shepard; E H Moore; J C Wain; D J Mathisen; H C Grillo
Journal:  Radiology       Date:  1992-02       Impact factor: 11.105

10.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?

Authors:  Fergus Davnall; Connie S P Yip; Gunnar Ljungqvist; Mariyah Selmi; Francesca Ng; Bal Sanghera; Balaji Ganeshan; Kenneth A Miles; Gary J Cook; Vicky Goh
Journal:  Insights Imaging       Date:  2012-10-24
View more
  55 in total

Review 1.  Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

Authors:  Christoph Frank Dietrich; Jouke Tabe Annema; Paul Clementsen; Xin Wu Cui; Mathias Maximilian Borst; Christian Jenssen
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Radiomics signature for the preoperative assessment of stage in advanced colon cancer.

Authors:  Yu Li; Aydin Eresen; Yun Lu; Jia Yang; Junjie Shangguan; Yury Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

3.  CT texture analysis of pancreatic cancer.

Authors:  Kumar Sandrasegaran; Yuning Lin; Michael Asare-Sawiri; Tai Taiyini; Mark Tann
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

4.  CT texture analysis in histological classification of epithelial ovarian carcinoma.

Authors:  He An; Yiang Wang; Esther M F Wong; Shanshan Lyu; Lujun Han; Jose A U Perucho; Peng Cao; Elaine Y P Lee
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

5.  MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.

Authors:  Jian Guo; Zhenyu Liu; Chen Shen; Zheng Li; Fei Yan; Jie Tian; Junfang Xian
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

6.  Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC.

Authors:  Raymond H Mak; Hugo J W L Aerts; Thibaud P Coroller; Vishesh Agrawal; Elizabeth Huynh; Vivek Narayan; Stephanie W Lee
Journal:  J Thorac Oncol       Date:  2016-11-27       Impact factor: 15.609

7.  Endometrial Carcinoma: Texture Analysis of Apparent Diffusion Coefficient Maps and Its Correlation with Histopathologic Findings and Prognosis.

Authors:  Ichiro Yamada; Naoyuki Miyasaka; Daisuke Kobayashi; Kimio Wakana; Noriko Oshima; Akira Wakabayashi; Junichiro Sakamoto; Yukihisa Saida; Ukihide Tateishi; Yoshinobu Eishi
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

8.  The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.

Authors:  Jinrong Qu; Chen Shen; Jianjun Qin; Zhaoqi Wang; Zhenyu Liu; Jia Guo; Hongkai Zhang; Pengrui Gao; Tianxia Bei; Yingshu Wang; Hui Liu; Ihab R Kamel; Jie Tian; Hailiang Li
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

Review 9.  Clinical applications of textural analysis in non-small cell lung cancer.

Authors:  Iain Phillips; Mazhar Ajaz; Veni Ezhil; Vineet Prakash; Sheaka Alobaidli; Sarah J McQuaid; Christopher South; James Scuffham; Andrew Nisbet; Philip Evans
Journal:  Br J Radiol       Date:  2017-10-27       Impact factor: 3.039

10.  Can radiomics features be reproducibly measured from CBCT images for patients with non-small cell lung cancer?

Authors:  Xenia Fave; Dennis Mackin; Jinzhong Yang; Joy Zhang; David Fried; Peter Balter; David Followill; Daniel Gomez; A Kyle Jones; Francesco Stingo; Jonas Fontenot; Laurence Court
Journal:  Med Phys       Date:  2015-12       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.